Ipilimumab increases activated T cells and enhances humoral immunity in patients with advanced melanoma. (Q50980327)
Jump to navigation
Jump to search
scientific article published in January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ipilimumab increases activated T cells and enhances humoral immunity in patients with advanced melanoma. |
scientific article published in January 2012 |
Statements
1 reference
Ipilimumab increases activated T cells and enhances humoral immunity in patients with advanced melanoma. (English)
1 reference
Sacha Gnjatic
1 reference
Jeffrey S Weber
1 reference
Omid Hamid
1 reference
Scott D Chasalow
1 reference
Dianna Y Wu
1 reference
Susan M Parker
1 reference
Susan Galbraith
1 reference
David Berman
1 reference
1 January 2012
1 reference
35
1 reference
89-97
1 reference
1
1 reference
Identifiers
1 reference